Among U.S. Protestant churchgoers, most say they read Scripture regularly, but just 31% say Bible reading is a daily habit.

For in the gospel a righteousness from God is revealed, a righteousness that is by faith from first to last, just as it is written: "The righteous will live by faith." This Good News tells us how God ...

Danish researchers were examining the use of medications during and after pregnancy when they noticed a clear trend: The number of women using weight-loss drugs like Ozempic and Wegovy soon after ...

Share on Pinterest A new study observed that people taking GLP-1 drugs had improved asthma symptoms. Felix Hörhager/picture alliance via Getty Images Researchers based in the United Kingdom recently ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. People with diabetes who were taking GLP-1 ...

TIX100 Demonstrates Safety and Tolerability in Human Subjects, Marking a Key Drug Development Milestone Post-Hoc Analysis Reveals Promising First Biological TIX100 Signal in Humans TIXiMED to Advance ...

-- Company to host a live webcast event with an expert panel of clinicians during EHA2025 -- REDWOOD CITY, Calif.--(BUSINESS WIRE)--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining ...

Almost every political conversation with white evangelicals today eventually comes down to their fear of saying anything positive about LGBTQ people. If you have empathy, they’ll warn it’s a slippery ...

New research reveals that young adults with higher body shame and weight concerns are more likely to consider GLP-1 medications, despite significant side effects, unless buffered by strong body ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for ...